Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 11/16/14  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Chris Ariyan

Wrong Chris Ariyan?

Senior Director

Pfizer Inc
235 E 42Nd St
New York, New York 10017
United States

Company Description: Pfizer Inc. (Pfizer) is a research-based, global pharmaceutical company. The Company discovers, develops, manufactures and markets prescription medicines for humans...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • MPH
  • Yale School of Public Health
  • MPH degree , healthcare Management
    Yale School of Management
  • B.A. , Psychology/Pre-Med
    University of Vermont
6 Total References
Web References
Board of Directors - REMEDY, Recovered Medical Equipment for the Developing World
remedyinc.org, 20 May 2014 [cached]
Chris Ariyan, MPH, Director
Mr. Ariyan is an Account Director for Pfizer Inc, in New York Cityaccountable for national Payor relationships. Prior to Pfizer, he was Staff Vice President with WellPoint, Inc. responsible for strategic planning and their best practice program. Prior to WellPoint, he was aHealthcare Consultant with Deloitte Consulting and Ernst & Young LLP. He was also Co-Founder and Executive Vice President of HealthInfo Corp, a web-based patient and physician education service.
HEALTHCARE VIDEOS - HEALTHINFO - videos, health, diagnosis, treatment
www.healthinfocorp.com, 30 July 2001 [cached]
Christopher S. Ariyan , MPHExecutive Vice President & Manager , Physician Education
...
Christopher S. Ariyan , MPHExecutive Vice President & Manager ,Physician Education
Mr. Ariyan was most recently a Senior Consultant with Ernst & Young LLP ( E&Y ) , in their healthcare Technology Enablement Practice.His work with Ernst & Young involved aiding healthcare organizations to assess their current operations and identify areas for process improvement through the implementation of information technology strategies.Mr. Ariyan has worked on numerous engagements for internationally recognized academic medical centers , integrated delivery systems , and for-profit hospital corporations.He has extensive experience developing Information System Strategic Plans , conducting vendor selections , and managing the implementation of hospital information systems.
Before joining E&Y , Mr. Ariyan was instrumental in the start-up of REMEDY Inc. , a not-for-profit organization focused on the cost-effective use of surgical supplies in U.S. hospital operating rooms.Shortly after its initial pilot period at Yale-New Haven Hospital , REMEDY was presented with the Rolex Award for Enterprise in 1996.
During his tenure at REMEDY , Mr. Ariyan published articles in a variety of national medical journals including the Journal of the American Medical Association ( JAMA ) , the American Journal of Orthopedics , and Plastic and Reconstructive Surgery.He also presented REMEDY protocols at major medical association conferences including the annual meetings of the American College of Surgeons , the American Society of Anesthesiologists , and the Plastic Surgery Education Foundation.Today , he continues to play an important role in the future direction of REMEDY as a member of its Board of Directors.
...
Mr. Ariyan attended the Yale School of Public Health and the Yale School of Management where he earned his MPH degree with a concentration in healthcare Management.Mr. Ariyan holds a B.A. in Psychology/Pre-Med from the University of Vermont.
Who We Are Products & Services Strength Sponsor Contact Us Site Map Home
Christopher Ariyan, Senior ...
www.pharmexec.com, 1 July 2013 [cached]
Christopher Ariyan, Senior Director/Team Leader U.S. Oncology Managed Markets, Pfizer Christopher Ariyan has always had a thing for innovation. But, he says, real examples of it have been difficult to find. And he's hardly been lazy in his quest-his career has run the gamut of organizations within healthcare. Before pharma, he earned his stripes working for hospital systems (via Ernst & Young), a payer (Anthem/WellPoint), a consultancy (Deloitte), and an international non-profit (REMEDY, Inc.). But it wasn't until he joined Pfizer five years ago that Ariyan could say that he witnessed-and got involved in-real innovation for the first time.
"Consulting seemed innovative: you did strategy work, you learned about people's problems," he says. "But in many cases the strategic plans you came up with sat on the shelf. On the payer side, we would have innovation sessions, but it essentially boiled down to how to more efficiently process claims and provide good customer service."
Pfizer, he says-particularly its Oncology Business Unit, in which he has led the Managed Markets team for the past two and a half years-is different. He attributes true innovation to its scientists, "some of whom have spent 30 years, their whole professional lives, coming up with cancer drugs that have a meaningful impact on society. But it's the unit's business innovations where Ariyan has made his mark.
In just 15 months, Ariyan has assisted the oncology unit through three product launches, which, by his own admission, is "almost a miracle. He has brokered payer access and oncology product distribution agreements that, formally, have not been done before, according to his Pfizer colleague Brian C. Denton, and he's resolved a problem of patient access and assistance through a new technology collaboration. Ariyan "has built the Oncology Managed Markets team from scratch and established the value of the National Oncology Account Management Team for Pfizer," adds Denton. "The national rating scores for the team have continued to increase significantly each year; Pfizer oncology account management rating scores are now in the upper third of all biopharma companies. Innovation, says Lance Reno, another Pfizer colleague, is something that Ariyan does on a daily basis.
...
Ariyan puts a lot of this success down to the way Pfizer works. With the company's newly rolled out "Own It" culture, staff have "the leeway to take more responsibility, more accountability, and, not least, take chances with a priority around speed to market," he says. "And it's okay to fail. But you learn from these mistakes, course correct, and go on to new heights."
For his part in "Own It," Ariyan is committed to leading by example. Lots of leaders pay lip service to that old chestnut, but Ariyan really rolls up his sleeves and gets down to it. "My team appreciates that I don't give out assignments that I don't do myself," he explains. "When I send out a business planning task, I've already taken a shot at one of the accounts, not just as a test but as an exercise with real-world data. I want to feel what it's like when I give these assignments out. He adds however that "Own It" doesn't mean "go it alone," especially at a company the size of Pfizer; he emphasizes that the collaboration with Managed Markets teammates in the other business units (Specialty Care, Primary Care, Established Products, etc.) is vital.
Ariyan's passion for what he does goes back to a friend and life-long mentor Sam Chauncey who was, at different points of his career, Secretary of Yale University, President of Gaylord Hospital, and Head of Yale's Health Management Program. "He opened my eyes to the business side of healthcare and the role it plays in helping people get access to critical care," he says. Ariyan's ongoing commitment to this cause spills into his home life. A lot of his family's time is spent participating in sporting events, and "very often they are in support of a non-profit cause, raising money for research for a medical condition, for example. These activities are even more special, he says, when Pfizer is an active sponsor of the event.
It is clear that-spurred on by his earlier career odyssey-Ariyan has found his "home" at Pfizer. And the feeling seems to be mutual. The company has enlisted him on the "Next Gen" leadership development program; ~two percent of the global senior director population get accepted for this. For Ariyan, however, his future plans remain all about playing a part in continuing to innovate, and bringing those cancer medicines to market as quickly as possible.
Christopher Ariyan, Senior ...
www.pharmexec.com, 1 July 2013 [cached]
Christopher Ariyan, Senior Director/Team Leader U.S. Oncology Managed Markets, Pfizer
Contact Us
www.supportremedy.com, 4 June 2010 [cached]
Christopher Ariyan
Other People with the name "Ariyan":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.